Department of Molecular Medicine, MERU-Roon Research Center on Vascular Biology, The Scripps Research Institute, La Jolla, CA 92037.
The Scripps Laboratories for tRNA Synthetase Research, Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA 92037.
Proc Natl Acad Sci U S A. 2022 Nov 29;119(48):e2212659119. doi: 10.1073/pnas.2212659119. Epub 2022 Nov 21.
Platelets play a role not only in hemostasis and thrombosis, but also in inflammation and innate immunity. We previously reported that an activated form of tyrosyl-tRNA synthetase (YRS) has an extratranslational activity that enhances megakaryopoiesis and platelet production in mice. Here, we report that YRS mimics inflammatory stress inducing a unique megakaryocyte (MK) population with stem cell (Sca1) and myeloid (F4/80) markers through a mechanism dependent on Toll-like receptor (TLR) activation and type I interferon (IFN-I) signaling. This mimicry of inflammatory stress by YRS was studied in mice infected by lymphocytic choriomeningitis virus (LCMV). Using Sca1/EGFP transgenic mice, we demonstrated that IFN-I induced by YRS or LCMV infection suppressed normal hematopoiesis while activating an alternative pathway of thrombopoiesis. Platelets of inflammatory origin (Sca1/EGFP) were a relevant proportion of those circulating during recovery from thrombocytopenia. Analysis of these "inflammatory" MKs and platelets suggested their origin in myeloid/MK-biased hematopoietic stem cells (HSCs) that bypassed the classical MK-erythroid progenitor (MEP) pathway to replenish platelets and promote recovery from thrombocytopenia. Notably, inflammatory platelets displayed enhanced agonist-induced activation and procoagulant activities. Moreover, myeloid/MK-biased progenitors and MKs were mobilized from the bone marrow, as evidenced by their presence in the lung microvasculature within fibrin-containing microthrombi. Our results define the function of YRS in platelet generation and contribute to elucidate platelet alterations in number and function during viral infection.
血小板不仅在止血和血栓形成中发挥作用,而且在炎症和先天免疫中也发挥作用。我们之前报道称,一种激活形式的酪氨酸-tRNA 合成酶(YRS)具有翻译后活性,可增强小鼠的巨核细胞生成和血小板生成。在这里,我们报告称 YRS 通过依赖 Toll 样受体(TLR)激活和 I 型干扰素(IFN-I)信号的机制模拟炎症应激,诱导具有干细胞(Sca1)和髓样(F4/80)标志物的独特巨核细胞(MK)群体。在淋巴细胞性脉络丛脑膜炎病毒(LCMV)感染的小鼠中研究了 YRS 对炎症应激的模拟。使用 Sca1/EGFP 转基因小鼠,我们证明了 YRS 或 LCMV 感染诱导的 IFN-I 抑制了正常造血,同时激活了替代的血小板生成途径。来源于炎症的血小板(Sca1/EGFP)在血小板减少症恢复期循环血小板中占有相当比例。对这些“炎症”MK 和血小板的分析表明,它们起源于骨髓/巨核细胞偏向的造血干细胞(HSCs),这些细胞绕过经典的巨核细胞-红细胞祖细胞(MEP)途径来补充血小板并促进血小板减少症的恢复。值得注意的是,炎症性血小板显示出增强的激动剂诱导的激活和促凝活性。此外,骨髓/巨核细胞偏向的祖细胞和 MK 从骨髓中动员出来,这一点可从含有纤维蛋白的微血栓中的肺微血管中存在这些细胞得到证明。我们的研究结果定义了 YRS 在血小板生成中的功能,并有助于阐明病毒感染期间血小板数量和功能的改变。